TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Perimeter Medical Imaging AI ( (TSE:PINK) ) has issued an update.
Perimeter Medical Imaging AI announced its participation in the Planet MicroCap Showcase in Toronto, where CEO Adrian Mendes will present updates on the company’s commercial strategy and upcoming milestones. This event, which gathers investors and analysts, provides Perimeter with an opportunity to enhance its industry positioning and engage with potential stakeholders, highlighting its focus on advanced imaging tools for cancer surgery.
The most recent analyst rating on (TSE:PINK) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on Perimeter Medical Imaging AI stock, see the TSE:PINK Stock Forecast page.
Spark’s Take on TSE:PINK Stock
According to Spark, TipRanks’ AI Analyst, TSE:PINK is a Neutral.
Perimeter Medical Imaging AI’s overall score is driven by financial challenges, including profitability and cash flow issues. Despite strong revenue growth and positive clinical trial results, the company’s financial health and valuation remain significant concerns.
To see Spark’s full report on TSE:PINK stock, click here.
More about Perimeter Medical Imaging AI
Perimeter Medical Imaging AI, Inc. is a medical technology company based in Toronto, Canada, and Dallas, Texas. It focuses on transforming cancer surgery through ultra-high-resolution, real-time imaging tools. The company’s FDA-cleared Perimeter S-Series OCT system provides real-time visualization of excised tissues at the cellular level, while its investigational Perimeter B-Series OCT with ImgAssist AI represents next-generation artificial intelligence technology.
Average Trading Volume: 55,992
Technical Sentiment Signal: Sell
Current Market Cap: C$28.51M
Find detailed analytics on PINK stock on TipRanks’ Stock Analysis page.